Cargando…
Rituximab and Fludarabine or Cyclophosphamide Combination Treatment for Older Waldenström Macroglobulinemia Patients
Autores principales: | Xu, XiaoWei, Wang, Chun, Wang, YaMin, Zhou, LiLi, Bai, HaiTao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Galenos Publishing
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3874973/ https://www.ncbi.nlm.nih.gov/pubmed/24385838 http://dx.doi.org/10.4274/TJH.2013.0030 |
Ejemplares similares
-
Interstitial pneumonitis related to rituximab therapy for Waldenström's macroglobulinemia
por: Bai, Xueyan, et al.
Publicado: (2015) -
Pseudohyperphosphatemia in Waldenstrom's Macroglobulinemia
por: Amalnath, S. D., et al.
Publicado: (2013) -
A Promising New Therapy of Oral Ixazomib Without Rituximab for Waldenstrom Macroglobulinemia
por: Ma, Wanlu, et al.
Publicado: (2021) -
Rituximab-based combination therapy in patients with Waldenström macroglobulinemia: a systematic review and meta-analysis
por: Zheng, Yan-Hua, et al.
Publicado: (2019) -
Successful Treatment of Rituximab-Refractory Waldenstrom Macroglobulinemia-Related Kidney Damage With Bruton Tyrosine Kinase Inhibitor
por: Nie, Guangyan, et al.
Publicado: (2021)